Diagnos Laboratorium Utama Tbk. vs Star Pacific Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 319B, 7.6K 24h volume), while Star Pacific Tbk trades at Rp246 (market cap 287.93B, 770.2K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. and Star Pacific Tbk are close in size by market cap, and Star Pacific Tbk is more actively traded (770.2K versus 7.6K). Which is the better fit depends on your goals.
| DGNS | LPLI | |
|---|---|---|
Market Cap | 319B | 287.93B |
Volume | 7.6K | 770.2K |
Lot | 76 | 7.7K |
Turnover | 1.74M | 197.59M |
Average Price | 229.21 | 256.54 |
Value | 1.74M | 197.59M |
Indicative Equilibrium Price | 232 | — |
Indicative Equilibrium Volume | 200 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Star Pacific Tbk (the Company), was established under the name of PT Asuransi Lippo Jiwa Sakti based on Deed No. 301 dated May 28, 1983 of Misahardi Wilamarta, S.H., a notary in Jakarta, which was amended by Deed No. 130 dated August 10, 1983 by the same notary, concerning the change of the Company's name to PT Asuransi Lippo Life. Furthermore, the Company's name was again changed to Lippo E-Net Tbk based on Deed No. 87 dated June 23, 2000 of Misahardi Wilamarta, S.H., a notary in Jakarta.
Read more on LPLI →